Daniela Gašperíková

机构：Institute of Chemistry of the Slovak Academy of Sciences, Slovak Academy of Sciences, Institute of Experimental Endocrinology of the Slovak Academy of Sciences · ORCID：0000-0002-5725-6424

发表论文 151 篇 · 总被引 4031 次 · h-index 33

代表论文

• Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study (2018 · The Lancet Diabetes & Endocrinology · 被引 176)
• Novel insights into genetics and clinics of the HNF1A-MODY (2019 · Endocrine Regulations · 被引 86)
• Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes (2020 · Diabetes Care · 被引 59)
• Clinical implications of the glucokinase impaired function – GCK MODY today (2020 · Physiological Research · 被引 46)
• Neonatal Hypoglycemia, Early-Onset Diabetes and Hypopituitarism Due to the Mutation in EIF2S3 Gene Causing MEHMO Syndrome (2018 · Physiological Research · 被引 34)
• Serum Afamin a Novel Marker of Increased Hepatic Lipid Content (2021 · Frontiers in Endocrinology · 被引 31)